Compared to Luminal A (ER+ PR+ HER2−) breast cancer subtype, Luminal B (ER+ PR+ HER2+), TNBC and HER2-enriched subtypes showed significantly higher expression of PANX1. This evidence concerns the gene ESR1 and breast carcinoma.